Medpace Holdings (MEDP) Notes Payables (2022 - 2023)
Medpace Holdings (MEDP) reported Notes Payables of $55.0 million for Q2 2023, down 77.97% on a YoY basis from $249.7 million in Q2 2022, and down 52.17% quarter-over-quarter from $115.0 million in Q1 2023.
Medpace Holdings (MEDP) Notes Payables (2022 - 2023) Analysis & Trends
Medpace Holdings has reported Notes Payables for 2 years, with the latest figure at $55.0 million in Q2 2023.
- For the quarter ending Q2 2023, Notes Payables fell 77.97% year-over-year to $55.0 million; the trailing twelve-month figure through Jun 2023 stood at $55.0 million (down 77.97% YoY), and the FY2022 full-year result was $50.0 million, changed N/A from the prior year.
- Notes Payables for Q2 2023 stood at $55.0 million, down from $115.0 million in the prior quarter.
- The five-year high for Notes Payables was $249.7 million in Q2 2022, with the low at $50.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | Medpace Holdings | 13.03 Bn | 12.38 Bn | 196.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 55.00 Mn |
| Mar 31, 2023 | 115.00 Mn |
| Dec 31, 2022 | 50.00 Mn |
| Sep 30, 2022 | 139.70 Mn |
| Jun 30, 2022 | 249.70 Mn |